| Endocrine arterial hypertension: therapeutic approach in clinical practice. | |
| | |
MedLine Citation:
|
PMID: 18594485 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
This review describes the therapeutic approach of endocrine arterial hypertension in clinical practice. In mineralocorticoid-related hypertension, adrenalectomy is the treatment of choice for aldosterone-producing adenomas and monolateral primary aldosteronism, whereas pharmacologic blood pressure (BP) control is indicated for the other forms of primary aldosteronism such as bilateral adrenal hyperplasia. Spironolactone is the drug of choice, but intolerable side effects limit its use; amiloride or eplerenone are a valid alternative. If BP remains uncontrolled, angiotensin converting enzyme inhibitors (ACE-I), angiotensin II receptor antagonists (AII-RA) and calcium channel blockers (CCB) may be added. Hypertension accompanying Cushing's syndrome can be approached with surgery, but antihypertensive treatment both pre- and postoperative is required as well. Eplerenone, AII-RA and ACE-I are indicated, while peroxisome proliferator activated receptor gamma-agonists may help for the insulin resistance syndrome. Drugs that suppress steroidogenesis should be used with care because of their serious side effects. Subjects with catecholamine-dependent hypertension due to a neuroendocrine neoplasm need to undergo preoperative alpha-adrenergic blockade with phenoxybenzamine or doxazozine. When adequate alpha-adrenergic blockade is achieved, beta-adrenergic blockade with low dose propranolol may be added. If target BP is not achieved, CCB and/or metyrosine are indicated. Laparoscopic adrenalectomy is the procedure of choice for solitary intra-adrenal neoplasms <8 cm. Acute hypertensive crises that may occur before or during surgery should be treated intravenously with sodium nitroprusside, phentolamine, nicardipine or labetalol. For malignant neoplasms, chemo- and radiopharmaceutical therapy may be considered. |
| | |
Authors:
|
A Mazza; M Armigliato; S Zamboni; P Rempelou; D Rubello; A C Pessina; E Casiglia |
Related Documents
:
|
7309905 - Effects of chronic prazosin treatment on the renin-angiotensin-aldosterone system in man. 1560165 - Hypertension during reduction of long-term steroid therapy in young subjects with asthma. 6996895 - Long-term effects of captopril in hypertension. 17134615 - Changes in central arterial pressure waveforms during the normal menstrual cycle. 11542355 - Venous tone and repeated +gz accelerations. 6773435 - Correction for gas compression in mechanical ventilators. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2008-7-3 |
Journal Detail:
|
Title: Minerva endocrinologica Volume: - ISSN: 0391-1977 ISO Abbreviation: Minerva Endocrinol. Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-7-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8406505 Medline TA: Minerva Endocrinol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Internal Medicine, Rovigo General Hospital, Rovigo, Italy. mazza.alberto@azisanrovigo.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: No Article Title
Next Document: How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2...